KYNTRA BIO, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for KYNTRA BIO, INC. (KYNB), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are KYNB insiders buying or selling?
KYNTRA BIO, INC. insiders reported 9 open-market buys ($1.5M) and 162 sells ($98.2M) across 171 Form 4 filings — a net selling position of $96.7M.
Source: SEC EDGAR Form 4
Key Statistics (as of May 19, 2026)
Insider sentiment
Net sellingNet insider flow of $96.7M in net selling. 1 insider buy in the last 90 days.
Recent KYNB insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 19, 2026 | Thane Wettig | CEO | Purchase | 2.8K | $7.09 | $19.9K |
| May 18, 2026 | Thane Wettig | CEO | Sale | 2.8K | $7.09 | $19.9K |
| Nov 17, 2025 | Thane Wettig | CEO | Purchase | 3.7K | $9.12 | $33.7K |
| Jul 2, 2025 | James A Schoeneck | Director | Purchase | 23.6K | $5.07 | $119.5K |
| Mar 25, 2025 | Thane Wettig | CEO | Purchase | 145.0K | $0.35 | $50.7K |
| Mar 24, 2025 | James A Schoeneck | Director | Purchase | 300.0K | $0.35 | $105.0K |
| Jun 13, 2024 | Deyaa Adib | Chief Medical Officer | Purchase | 22.1K | $1.17 | $25.9K |
| Mar 11, 2024 | Thane Wettig | CEO | Purchase | 50.0K | $1.91 | $95.5K |
| Sep 7, 2023 | Jeffrey William Henderson | Director | Sale | 2.0K | $1.03 | $2.1K |
| Aug 8, 2023 | Jeffrey William Henderson | Director | Sale | 2.0K | $1.91 | $3.8K |
| Jul 14, 2023 | Jeffrey William Henderson | Director | Sale | 2.0K | $2.69 | $5.4K |
| Jul 10, 2023 | Enrique A Conterno | Chief Executive Officer | Sale | 1.9K | $2.80 | $5.3K |
| Jun 26, 2023 | Thane Wettig | Chief Commercial Officer | Sale | 791 | $16.53 | $13.1K |
| Jun 22, 2023 | Thane Wettig | Chief Commercial Officer | Sale | 1.8K | $17.04 | $30.0K |
| Jun 16, 2023 | Christine Chung | SVP, China Operations | Sale | 12.5K | $17.19 | $214.9K |
| Jun 9, 2023 | Benjamin Cravatt | Director | Sale | 3.9K | $17.17 | $67.7K |
| Jun 9, 2023 | Aoife Brennan | Director | Sale | 4.7K | $17.19 | $81.4K |
| Jun 9, 2023 | Suzanne Blaug | Director | Sale | 8.5K | $17.20 | $146.6K |
| Jun 9, 2023 | Maykin Ho | Director | Sale | 8.5K | $17.44 | $148.6K |
| Jun 9, 2023 | Jeffrey L Edwards | Director | Sale | 7.9K | $17.19 | $135.6K |
| Jun 9, 2023 | Jeffrey William Henderson | Director | Sale | 7.0K | $17.46 | $122.2K |
| Jun 9, 2023 | James A Schoeneck | Director | Sale | 7.1K | $18.03 | $128.0K |
| Jun 9, 2023 | Thane Wettig | Chief Commercial Officer | Sale | 1.8K | $17.04 | $30.0K |
| Jun 9, 2023 | Juan Graham | Chief Financial Officer | Sale | 1.8K | $16.99 | $30.3K |
| Jun 9, 2023 | Christine Chung | SVP, China Operations | Sale | 3.6K | $17.04 | $61.9K |
Showing the 25 most recent of 171 Form 4 filings for KYNTRA BIO, INC..
Most active KYNB insiders
- Thomas B Neff31 filings
- Kalevi Kurkijarvi24 filings
- Pat Cotroneo19 filings
- Christine Chung17 filings
- Thane Wettig13 filings
Ask anything about KYNB insider activity
Use Trabud's AI agent to query KYNTRA BIO, INC.'s Form 4 history in plain English — "Show me KYNB CEO purchases this year" or compare it against any other ticker.
Open the AI agentKYNB insider trading FAQ
Are KYNTRA BIO, INC. insiders buying or selling?
Across 171 SEC Form 4 filings, KYNTRA BIO, INC. (KYNB) insiders reported 9 open-market purchases totaling $1.5M and 162 sales totaling $98.2M. That is a net selling position of $96.7M.
How many insiders trade KYNB stock?
22 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for KYNTRA BIO, INC.. The most recent filing was accepted on May 19, 2026.
Where does Trabud get KYNB insider trading data?
All KYNB insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.